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Abstract
Purpose Health state valuations, used to evaluate the
effectiveness of healthcare interventions, can be obtained
either by the patients or by the general population. The
general population seems to value somatic conditions more
negatively than patients, but little is known about valua-
tions of psychological conditions. This study examined
whether individuals with and without depression differ in
their valuations of depression and whether perceptions re-
garding depression (empathy, perceived susceptibility,
stigma, illness perceptions) and individual characteristics
(mastery, self-compassion, dysfunctional attitudes) bias
valuations of either individuals with or without depression.
Methods In an online study, a general population sample
used a time-trade-off task to value 30 vignettes describing
depression states (four per participant) and completed
questionnaires on perceptions regarding depression and
individual characteristics. Participants were assigned to
depression groups (with or without depression), based on
the PHQ-9. A generalized linear mixed model was used to
assess discrepancies in valuations and identify their
determinants.
Results The sample (N = 1268) was representative of the
Dutch population on age, gender, education and residence.
We found that for mild depression states, individuals with
depression (N = 200) valued depression more negatively
than individuals without depression (N = 1068)
(p = .007). Variables related to perceptions of depression
and individual characteristics were not found to affect
valuations of either individuals with or individuals without
depression.
Conclusion Since the general population values depres-
sion less negatively, using their perspective might result in
less effectiveness for interventions for mild depression.
Perceptions of depression or to individual characteristics
did not seem to differentially affect valuations made by
either individuals with or without depression.
Keywords Depression  Discrepancies  Valuations 
Health-related quality of life  Time-trade-off
Introduction
Depression is a prevalent condition [1] that imposes a high
burden on health-related quality of life [2–4]. Various types
of interventions have been found effective in alleviating
depression [5–7]. Economic evaluations of healthcare in-
terventions are currently necessary for policy decisions.
Cost-utility analysis is a type of economic evaluation in
which health state valuations (also called ‘‘utility values,’’
‘‘utilities’’ or ‘‘preferences’’) are the recommended metric
measures to assess the effectiveness of the intervention [8].
Currently, cost-utility analyses are primarily used in the
evaluation of interventions for somatic conditions but are
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less frequently used in evaluating interventions for mental
conditions such as depression [9].
A question that has generated ongoing discussion, with
possibly serious policy implications, is whose values
should be used in evaluating health conditions: those ex-
pressed by the patients experiencing the health states or
those expressed by the general population imagining them
[10]. This issue has been extensively debated [11] in light
of evidence showing that patients and the general popula-
tion differ in their valuations of health conditions.
Theoretically, the general population should be less biased
in their valuations due to lack of self-interest; on the other
hand, patients should be better informed on their condi-
tions. Studies on valuations of somatic conditions show
that somatically ill patients tend to value their states less
negatively than the general population [12, 13], although
this finding is not consistent [14, 15]. Consequently, if a
condition is valued more negatively by the general
population, more favorable conclusions can be expected
regarding the efficacy of an intervention for a somatic
condition when using the valuation of the population rather
than the patient perspective.
Much less is known about valuations of depression [16]
and the role of individuals’ own state of depression in
making such valuations. Two relevant studies have inves-
tigated depression valuations, both showing that indi-
viduals who experience depression value hypothetical
depression states more negatively that those who do not
[17, 18]. This less negative valuation of depression by the
general population entails that evaluations of depression
interventions, in contrast to interventions for somatic
conditions, would result in conclusions of less efficacy
when using the population’s perspective. However, current
evidence is insufficient to draw firm conclusions, given the
limited number of studies and their methodological short-
comings. In the previous studies, discrepancies were ob-
served between individuals without depression and
individuals experiencing severe levels of depression. Fur-
thermore, a limited number of hypothetical depression
states were included (mild, moderate and severe depres-
sion), which may not have reflected the variety of different
states of depression, characterized by different levels of
dysfunction across health-related quality of life domains.
Moreover, discrepancies were more prominent when a
rating scale was used rather than the standard gamble
method, although the latter method has been considered
more appropriate [19]. Thus, the first aim of this study was
to investigate whether discrepancies in valuations of de-
pression occur between individuals with and without
depression.
The existence of discrepancies in valuations made by
individuals with and without depression, if found, may
carry policy implications, making the question of whose
values to use in evaluations more critical. To inform this
choice of perspective, it is also important to understand the
underlying mechanisms of the discrepancies, which was
the second aim of this study. Relevant research, although
limited, exists regarding valuations for somatic conditions,
in which a number of factors have been suggested as in-
fluencing over- and/or under-valuations by the patients or
by the general population [20, 21]. Patients’ adaptation to
their conditions [22] as well as the general population’s
attention to the negative aspects of the conditions [23] have
both been found to explain why patients value somatic
conditions less negatively than the population. For de-
pression, some suggestions have thus far been made con-
cerning factors that account for observed discrepancies in
valuations between individuals with and without depres-
sion. The effect of these suggested factors has never been
empirically investigated. Among such factors, dysfunc-
tional attitudes (for example, black and white thinking)
have been suggested to relate to downward bias in valua-
tions of individuals with depression, whereas stigma to-
ward depression (for example: ‘‘They could snap out of
depression if they really wanted’’) has been proposed to
account for upward biases in valuations of individuals
without depression [18].
Following and expanding on this line of thought, we
hypothesized that potential discrepancies in valuations of
depression can be explained by differences between indi-
viduals with and without depression with regard to how they
perceive depression and with regard to their individual
characteristics. We expected that depression, like other
mental conditions with an unclear nature and cause, can be
more prone to subjectivity in how it is perceived by those
with no experience of it. More specifically, we expected that
individuals without depression might differ from those with
depression with regard to stigma (for example, whether
depression is a ‘‘real’’ disease), empathy (the degree to
which the experience of being in depression can be under-
stood), perceived susceptibility (whether depression can
occur to oneself) and illness perceptions (whether depres-
sion is treatable, what its consequences are). We, therefore,
hypothesized that this subjectivity in the perceptions of
depression by individuals who do not experience it could be
related to the discrepancies in valuations of depression be-
tween individuals with and without depression. In addition,
we expected that individuals who experience depression
would differ from those who do not experience depression
with regard to individual characteristics known to relate to
depression, specifically levels of mastery, self-compassion
and dysfunctional attitudes. We expected lower levels of
mastery and self-compassion and higher level of dysfunc-
tional attitudes among individuals with depression com-
pared with individuals without depression, and we
hypothesized that these differences in characteristics might
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be related with the discrepancies in how they value de-
pression. Our purpose was to determine whether the
valuations of individuals with depression or the general
population were affected by subjectivity in perceptions of
depression, by individual characteristics related to depres-
sion or by both. We considered this question important for
determining whose valuations can be considered more valid
and legitimate.
Through the current study, we aimed to investigate
whether individuals with and without depression differ in
their valuations of depression. To overcome the limitations
of previous studies on this subject, we conducted a large-
scale valuation study using a wide range of hypothetical
depression states based on a standard depression-specific
classification system, and we elicited valuations using the
time-trade-off (TTO) method. Furthermore, we examined
whether potential differences can be related to group dif-
ferences in perceptions of depression, by individual char-
acteristics or by both.
Methods
Participants and procedures
This project consisted of a cross-sectional nationwide study
conducted among members of the Dutch population. Par-
ticipants included in this study were at least 18 years old,
were able to understand Dutch and provided informed
consent. Recruitment was conducted via an existing panel
of an international company specialized in sampling for
marketing and academic research [24]. To ensure repre-
sentativeness of the sample, we used a stratified sampling
strategy with strata based on gender, age, educational
background and place of residence (across the 12 provinces
of the Netherlands). In the first part of the survey, we
collected data on participants’ demographic characteristics
and health statuses. In the second part, after being trained
in the valuations tasks, each participant valued a total of
four vignettes describing different states of depression. In
the third part, participants filled out a questionnaire related
to their experiences with chronic conditions and depres-
sion, their perceptions of depression and their individual
characteristics. The study protocol was reviewed by the
Medical Ethical Committee of the University Medical
Center Groningen, and a waiver was provided
(M12.119685). We pilot-tested the instruments with 200
participants. Data regarding the difficulty of the tasks,
completion time and the construct validity of valuations
supported the feasibility of the study protocol. These data
were only used for pilot purposes. Primary data collection
took place online using software developed for this study
by the same company that recruited the participants.
Vignettes of depression health states
Thirty vignettes with descriptions of different depression
states were developed. Each participant was randomly
presented four of a total of 30 vignettes, and the order of
presentation was randomized. Depression states were based
on the McSad depression-specific classification system
[25], previously translated and validated in Dutch [26]. The
McSad consists of six depression-specific health-related
quality of life domains: Emotion, Self-appraisal, Cogni-
tion, Physiology, Behavior and Role function. Each domain
could be categorized using one of the four levels of dys-
function, namely ‘‘no,’’ ‘‘mild,’’ ‘‘moderate’’ or ‘‘severe’’
dysfunction. Different combinations of the four levels
across the six domains make it possible to generate 4096
(46) different states. For example, the state with the profile
‘‘343433’’ describes moderate dysfunction in the Emotion,
Cognition, Behavior and Role functioning domains and
severe dysfunctioning in the Self-appraisal and Physiology
domains. To include depression states with different
combinations of the four levels of dysfunction across the
six domains, we used the orthogonal procedure (SPSS),
which generated 25 states based on the McSad classifica-
tion system. Another five states, more consistent with re-
spect to level of dysfunction across the six domains, were
added. Table 1 provides an example of the description of a
depression state (‘‘222222’’).
The 30 depression states were rated in terms of their
severity (as mild, moderate or severe) by three mental
healthcare professionals (two clinical psychologists and
one psychiatrist), all specialized and experienced in
working with individuals with depression. They first in-
dependently rated the 30 states, and inter-rater agreement
was strong (Kendall’s W = .773) [27]. Initial discrepancies
among the ratings were resolved through discussion,
achieving a final consensus of four states rated as ‘‘mild,’’
17 as ‘‘moderate’’ and nine as ‘‘severe.’’
Valuation elicitation procedure
To elicit valuations of depression, we used the TTO
method, which has been shown to be a reliable and valid
method [19] in previous evaluations of mental health
conditions [28, 29]. In the TTO, participants are asked to
imagine and choose between two options. The first option
involves living in the health state described for another
10 years and then dying. The second option involves full
recovery from this state, but living for less than 10 years.
The number of years in the second option varies, until the
point of indifference between Choice A and Choice B is
reached.
In the current study, participants were trained in the use
of the TTO method using a vignette describing asthma. A
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ping-pong iteration method was used [30]. An interactive
horizontal scale representing the life years (0–10) was used
as a visual aid. In the primary valuation tasks, the ping-
pong method was skipped, and participants could use the
interactive scale directly and report the point of indiffer-
ence between Choice A and Choice B. We chose this op-
tion because the pilot testing indicated that using the ping-
pong method for multiple states was tiring for participants.
The value attached to the health state was calculated based
on the TTO as 1 - (xmax/10), where xmax is the maximum
years the participant was willing to trade to live free of
depression. The value could therefore range from 0 to 1,
with lower values representing more negative valuations.
Upon completion, participants were asked to use a five-
point scale (with 1 being ‘‘not difficult at all’’ and 5 being




To assign participants to one of the two depression groups
(‘‘with depression’’ or ‘‘without depression’’), we used the
cutoff of 10 on the Patient Health Questionnaire—9-item
scale (PHQ-9) [31]. The PHQ-9 is an established scale,
previously validated in the Dutch language [32], consisting
of nine items corresponding to DSM depression symptoms,
such as reduced interest or difficulty sleeping. The ques-
tions relate to the frequency of depressive symptoms ex-
perienced during the last 2 weeks, and answers are
provided on a four-point scale, ranging from 0 (‘‘not at
all’’) to 3 (‘‘almost every day’’). Item scores are summed up
to calculate a total score, which ranges from 0 to 27, with
higher scores representing higher levels of depression. The
PHQ-9 has established psychometric properties among the
general population [31]. The cutoff of 10 has been rec-
ommended to indicate the presence of major depression
[31, 33]. Results on the PHQ-9 in the current study
demonstrated good internal consistency (Cronbach’s alpha:
.92), comparable to what has been previously reported [31,
34].
Explanatory factors of potential discrepancies
between individuals with and without depression
Empathy was assessed using the Emotional subscale of
Batson and colleagues’ Empathy scale [35].The six items
of the scale are words describing emotions (e.g., ‘‘sympa-
thy’’), and participants are asked to what degree they ex-
perienced each emotion (from 1: ‘‘not at all’’ to 6: ‘‘very
much’’) when reading a vignette describing a woman who
experiences depression. Total scores range from 6 to 36,
with higher scores representing higher levels of empathy.
The Perceived Susceptibility scale [36] was used to assess
to what extent participants perceived themselves suscepti-
ble to depression. The scale includes four items (e.g.,
‘‘What do you believe is the chance that you will develop
depression in your lifetime?’’) with varying answer cate-
gories. Total scores range from 4 to 22, with higher scores
indicating higher perceived susceptibility to depression.
Cognitive representations of depression were assessed
Table 1 Example of two vignettes describing McSad depression state ‘‘222222’’ and ‘‘444444’’
Emotion You feel more down than usual and you don’t enjoy things as usual
Self-appraisal You don’t feel very good about yourself these days and you often see the down side of everything
Cognition You have some trouble concentrating and remembering these days, and it seems harder to make decisions
Physiology Your sleep is a little troublesome these days. You don’t have quite the normal get up and go and you gave
less of an appetite
Behavior Things are more of a chore these days and at times you feels sluggish or agitated
Role function You are able to function okay at work, home, school or with friends, but often don’t enjoy what you are doing
Emotion You feel terribly down or sad all the time. You don’t enjoy anything and you feel desperate
Self-appraisal You feel worthless and see absolutely no hope for yourself, or you don’t know why people even care about you,
or you feel very guilty about the past and see no future for yourself
Cognition You feel like your mind is shut down, overloaded or racing. You can’t read or watch TV and you can’t make
even little decisions
Physiology Your sleep is terrible these days and you don’t feel rested. You have absolutely no energy and you feel constantly
tired. You have no interest in food and you have lost a lot of weight over the last month
Behavior You can’t do anything. You are completely shut down, or extremely agitated, or, you don’t see any perspective,
and wonder whether you wouldn’t be better off dead
Role function You had to stop work, or you do nothing at home, or have completely withdrawn from everything
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using the subscales of Consequences, Treatment Control
and Timeline Cyclical from the revised Illness Perception
Questionnaire (IPQr) [37], Dutch version [38]. The number
of items differs per subscale (example item: ‘‘Depression
does not have much effect on one’s life’’). Total scores for
the Consequences, Treatment Control and Timeline Cycli-
cal subscales range from 6 to 30, 5 to 25 and 4 to 20,
respectively. The Stigma for Depression scale [39], used to
assess personal stigma for depression, includes nine items
(e.g., ‘‘People with depression could snap out of it if they
wanted’’), with a tenth item added by our group following
content validity assessments. The scale’s total score ranges
from 0 to 40, with higher scores indicating higher stigma.
Mastery was measured by means of the Dutch version [40]
of the Pearlin Mastery scale [41]. The scale includes seven
items (e.g., ‘‘I have little control over things that happen to
me’’), with five answer categories and total scores ranging
from 7 to 35. Higher scores indicate higher mastery. The
Brief Self-Compassion scale, available in Dutch [42], was
used to assess self-compassion. It includes 12 items, to be
answered on a seven-point scale. The total score is com-
puted as the mean of item scores and, therefore, ranges
from 1 to 7, with higher scores indicating higher self-
compassion. Dysfunctional attitudes were assessed using
the Perfectionism subscale of the Dutch version of the
Revised Dysfunctional Attitudes scale [43]. The scale
consists of eleven items (e.g., ‘‘If I fail at my work, then I
am a failure as a person’’), and answer categories range
from 1 to 7. Total scores ranges from 11 to 77, with higher
scores indicating less dysfunctional attitudes. Validated
Dutch versions were used for all of the scales. As validated
Dutch versions were not available for the scales assessing
Stigma for Depression, Perceived susceptibility and Em-
pathy, we used established translation guidelines [44, 45]
to forward–backward translate these scales into Dutch and
then back into English.
Additional information
Information was collected on participants’ gender, age,
nationality, place of residence, education, family situation,
occupation and religious background. Generic health status
was also assessed by means of the EQ-5D ? C variant
health status classification system and visual analogue
scale [46, 47]. Additional questions concerned previous
diagnoses of a list of 23 chronic conditions, other than
depression. Furthermore, we collected self-reported infor-
mation concerning previous diagnoses of depression by a
psychiatrist or a psychologist, previous depressive episodes
or experience with depression via close friends or family.
This information was collected to better describe our
sample and to control for their effect when searching for
discrepancies in valuations based on depression status.
Analysis plan
To answer our first research question concerning discrep-
ancies in valuations of depression between individuals with
and without depression, we first defined the two depression
groups, described them and compared them to each other
and to the general population, using Chi-square and t tests.
We then aimed to test the effect of the depression group
(defined as the predictor variable) on valuations (defined as
the outcome variable). Given that the valuations represent a
scale from 0 to 1 using discrete increments of .05, the
frequency distribution of the valuations was approximated
with a binomial distribution in which the proportion rep-
resents a 0–1 scale. A binomial distribution would ap-
proximate a normal distribution when no floor or ceiling
effects are present. The binomial proportions were modeled
using a logit link function. To account for the correlation
among the four valuations per subject, a random intercept
for subjects was included in the binomial proportion. The
effect of the depression group on valuations, including an
interaction term with the severity of the depression state,
was tested using the Wald test, controlled for demographic
variables that were related to both the depression group and
the valuations, as well as for the depression states within
the severity groups. The mean valuations were estimated
for the ‘‘with depression’’ and the ‘‘without depression’’
groups separately for mild, moderate and severe states of
depression. To reduce the possibility of biases in valuations
due to inappropriate completion of the TTO task, we re-
peated the analyses, excluding those participants who were
not willing to trade any years or who traded the same
number of years for all four of the vignettes presented to
them.
When the effect of the depression group was significant,
for all severity states or just one severity group, we re-
peated the same analysis for the relevant severity groups,
by examining the effect of variables related to perceptions
of depression and individual characteristics on the valua-
tions. Both the main effect of these variables and their
interaction with the depression group were investigated.
We used the basic model previously described, with
valuations as the outcome variable and demographic vari-
ables and depression group as predictor variables. To this
model, we added each of the six variables (empathy, per-
ceived susceptibility, illness perceptions, mastery, self-
compassion and dysfunctional attitudes) one by one as
predictors, to examine for main effects. To examine in-
teractions, for each of these six variables, we added an
interaction term with depression group to our model. Our
hypothesis was that certain variables would affect the
valuations of either the ‘‘with depression’’ or the ‘‘without
depression’’ groups, resulting in discrepancies in valuations
between the two groups. For example, dysfunctional
Qual Life Res (2015) 24:2565–2575 2569
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attitudes might affect valuations of individuals with de-
pression, resulting in lower valuations. Therefore, we ex-
amined the depression group (‘‘with depression’’ or
‘‘without depression’’) as a moderator in the relationship
between the aforementioned variables and valuations of
depression. For this purpose, we examined the interaction
effect of each of the aforementioned variables, with the
depression group as a predictor of depression valuations.
The analysis was conducted using the GLIMMIX pro-
cedure of the SAS/STAT software [48], a generalized
linear mixed model that extends the class of generalized
linear models (GLMs) by incorporating normally dis-
tributed random effects. This procedure was considered
appropriate, given the structure of our data, specifically the
correlations among the responses. A difference of .05 in
valuations was considered meaningful [49, 50], and sta-
tistical significance was assessed at the .05 level.
Results
Sample
From the 2278 individuals who were invited to participate,
1268 (55.6 %) completed the survey. A flowchart of
dropouts for the different stages of the survey is presented
in Fig. 1. Table 2 provides a description of the final sam-
ple. Chi-square tests confirmed the representativeness of
the sample within the Dutch population with regard to age,
gender, place of residence and educational background.
Using the PHQ-9 cutoff score of 10, 200 participants
(15.8 %) were assigned to the ‘‘with depression’’ group, a
percentage relatively higher from the 10 % previously re-
ported [34]. In the whole sample, the majority of par-
ticipants reported either no (44.2 %) or minor (24.5 %)
difficulties with understanding the valuation task.
Discrepancies in valuations between individuals
with and without depression
Among the participant variables, age, family situation and
experience with chronic conditions were found to be cor-
related with depression group (‘‘with depression’’ or
‘‘without depression’’) and with valuations. We, therefore,
controlled for these three variables in our analysis. Addi-
tionally, we controlled for the different depression states
within the same severity group. Results of the generalized
linear mixed models (GLMM) analysis demonstrated a
significant interaction effect between the severity of the
depression states and the depression group on valuations of
depression (F = 3.22; p = .04). This interaction effect
indicated that the effect of the presence of depression on
valuations was different among depression states of dif-
ferent severity. A significant and clinically meaningful
difference in estimated mean values between ‘‘with de-
pression’’ and ‘‘without depression’’ groups was observed
for mild, but not for moderate or severe depression states
(see Table 3). Individuals with depression valued mild
depression lower, and thus more negatively, compared with
individuals without depression. When we repeated the
same analysis excluding participants who were not willing
to trade any years (N = 104, 8.2 %) or who traded the
same number of years for all four of the states presented to
them (N = 154, 12.1 %), only minor changes in the results
were observed. The interaction effect between the severity
of depression states and the depression group on valuations
of depression remained significant, and similar differences
were found in estimated mean values between the two
depression groups.
Explanatory factors for discrepancies
between individuals with and without depression
Depression groups differed in their average scores on all of
the variables related to perceptions of depression and in-
dividual characteristics, except for stigma and perceptions
concerning treatment control (see Table 3). As hy-
pothesized, individuals without depression reported lower
levels of empathy and perceived susceptibility, and they
perceived depression to be related to fewer consequences
and a more cyclical timeline. Individuals with depression
showed lower levels of mastery and self-compassion and
higher levels of dysfunctional attitudes.
After controlling for age, family situation, experience
with chronic conditions and the depression states within the
severity groups, we examined the variables related to
perceptions of depression and individual characteristics as
predictors of depression valuation, separately for each level
of depression (mild, moderate and severe). Self-compas-
sion (p = .045) and dysfunctional attitudes (p = .013)Fig. 1 Study flow diagram
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Table 2 Description of the two depression groups
With depression Without depression Comparea Sample (%) Population (%) Compareb
N = 200 % N = 1068 %
General
Gender
Female 119 59.5 529 49.5 v2(1) = 6.70
p = .011
51.1 51 p = .76
Age
Mean (SD) 42.04 (16.17) 47.53 (17.50) t = 4.35
p\ .000
18–35 71 35.5 287 26.9 v2(3) = 26.79
p\ .000
28.2 27.0 p = .98
36–50 75 37.5 296 27.7 29.3 28.0
51–65 38 19.0 264 24.7 23.8 25.0
65? 16 8.0 221 20.7 18.7 20.0
Education
Low 76 38.0 340 31.8 v2(2) = 5.67
p = .059
32.8 34.3 p = .95
Middle 86 43.0 446 41.8 42.0 42.1
High 38 19.0 282 26.4 25.2 23.5
Family situation
With partner 109 54.5 704 65.9 v2(1) = 9.54
p = .002Single/other 91 45.5 364 34.1
Children
Yes 95 54.7 650 60.9 v2(1) = 12.41
p = .001
Occupation
Paid job 50 25.0 413 23.7 v2(2) = 13.62
p = .001Education 26 13.0 118 13.7
Other 124 57.0 537 62.6
Religion




Yes 141 70.5 546 51.1 v2(1) = 25.48
p\ .000
EQ-6D VAS
Mean (SD) 63.17 (18.53) 80.99 (15.22) t = 12.813
p = .000
Depression
Under treatment 72 36.0 59 8.1 v2(1) = 101.5
p\ .000
Diagnosed-ever 108 54.0 179 16.8 v2(1) = 133.4
p = .000
Episode-ever 152 76.0 370 34.6 v2(1) = 118.9
p\ .000
Experience-others 113 56.5 323 30.1 v2(1) = 51.47
p\ .000
a Compare ‘‘with depression’’ and ‘‘without depression’’ groups
b Compare sample (whole) to the general Dutch population
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were found to significantly affect valuations of mild de-
pression, with higher levels of self-compassion and less
dysfunctional attitudes related to higher, and thus less
negative, valuations. Perceptions concerning consequences
of depression (p = .020) and treatment control (p = .001)
were found to affect valuations of moderate depression
states, with higher valuations related to stronger beliefs that
depression has major consequences and that treatment can
control depression. Empathy (p = .022) and perceived
susceptibility (p = .002) were found to affect valuations of
severe depression states, with higher valuations related to
less stigma for depression and lower levels of perceived
susceptibility to depression. When examined, the interac-
tion term for each of these predictor variables with the
depression group was never found to be significant,
meaning that for none of these variables was their asso-
ciation with valuations different for the two groups. This
result held for all of the different levels of depression
severity. Therefore, the depression groups was not found to
moderate the effect of the predictor variables on valuations,
or in other words, the effect of the predictor variables on
depression valuations was not different between indi-
viduals with and without depression. This implies that
discrepancies in valuations did not seem to relate to dif-
ferences between individuals with and without depression
with regard to their perceptions of depression or to their
individual characteristics.
Discussion
Results of this study answer our first research question
concerning discrepancies between individuals with and
without depression in valuations of depression states.
Specifically, results show that individuals with and without
depression differ in their valuations of mild hypothetical
depression states, with individuals with depression valuing
mild states of depression more negatively than those
without depression. For moderate and severe depression
states, no discrepancies between individuals with and
without depression were observed. Concerning the second
research question, results show that, although individuals
with and without depression differ in their perceptions of
depression and their individual characteristics, these dif-
ferences do not account for the observed discrepancies in
their valuations. Our results are in line with and add
specificity to results from previous studies showing more
negative valuations of hypothetical depression states by
individuals who experience depression. Previous studies
report that discrepancies are dependent on the severity of
the hypothetical depression state, with discrepancies
mainly observed for hypothetical states of mild severity. In
addition, discrepancies were previously reported only be-
tween individuals without depression and a specific sub-
group of individuals with depression, rather than between
the two groups [17, 18]. In this study, we compared indi-
viduals with and without depression overall, rather than
subgroups, and we found that discrepancies do exist for
valuations of mild depression. This finding is more valu-
able than those from previous studies, as the research
question seeks to compare and to identify whether dis-
crepancies occur between those who experience depression
and those who do not, to understand the implications of
choosing one of the two perspectives. Additionally, we
examined the effect of the severity of the valued state.
This study was the first to investigate whether observed
discrepancies between individuals with and without de-
pression in valuations of depression can be explained by
factors related to either the perceptions of depression by
those who do not experience it (e.g., stigma or low em-
pathy) or to individual characteristics known to be related
to depression (e.g., low mastery or higher dysfunctional
attitudes). As expected, individuals with and without de-
pression differed with respect to how they perceive de-
pression, with individuals without depression holding
lower levels of empathy, higher levels of perceived sus-
ceptibility, lower perceived consequences of depression
and the perception of a less cyclical timeline. With respect
to their individual characteristics, individuals without de-
pression showed higher levels of mastery and self-com-
passion and lower levels of dysfunctional attitudes.
However, the effect of these factors on how the individuals
value depression was not different between individuals
with and without depression for any of the three severity
levels of the hypothetical depression states. This finding
implies that, although discrepancies occur between
Table 3 Estimated mean
valuationsa for the ‘‘with
depression’’ and the ‘‘without
depression’’ group, separately
for groups of depression states
of different severity
Severity of the depression state With depression Without depression p value
M (SD) M (SD)
Mild .693 .776 .007
Moderate .653 .709 .080
Severe .604 .659 .111
a Based on the GLMM; controlled for age, family situation, experience with chronic conditions and the
states within severity groups
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individuals with and without depression in their percep-
tions of depression and their individual characteristics and
discrepancies also occur in their valuations of depression,
the earlier differences cannot explain the latter, as
hypothesized.
One of the strengths of the current study is the inclusion
a large sample of participants, representative of the Dutch
population with respect to age, gender, place of residence
and educational background. Furthermore, the sample in-
cluded a group of participants with depression that varied
with respect to the years since diagnosis and the state of
treatment. In contrast to previous studies, we have included
a large number of depression states, ensuring a large
variance with respect to the level of dysfunction in the
various domains, thus supporting the generalizability of our
findings.
When interpreting the results of the current study, cer-
tain limitations should be considered. First, although we
used the recommended cutoff score of an established scale
to assess depression [51], inclusion of participants diag-
nosed with depression by a healthcare professional might
have been more accurate. In addition, our results might
have been affected by the fact that participants recognized
to experience depression might not have been aware that
their symptoms can constitute a diagnosis of depression.
Furthermore, following the standard TTO formulation, we
asked participants to imagine living in the described states
of depression for another 10 years. Yet if, as in reality,
depression were described as a condition with fluctuations
between depression and remission, different valuations
might have been obtained. The range of observed mean
values between the mildest and the most severe depression
states was rather small (a range of .15 for the ‘‘without
depression’’ group and of .13 for the ‘‘with depression’’
group). In previous studies, the differences between the
mildest and the most severe states were also relatively
small. In the study by Gerhards et al. [17], the largest
difference was 12.52 in a 100-point rating scale and was
observed in the group with no depression, while the
smallest difference was 4.98, observed in the group with
severe depression. In the study by Pyne et al. [18], max-
imum difference in standard gamble-based valuations be-
tween the mild and severe depression state was observed in
the general population group (.24), whereas minimum
differences were found in the group with severe depression
(.19). This finding might be explained by the condition-
specific nature of the description, but might also have made
it more difficult to recognize discrepancies in valuations
between the two groups. Interview-based administration of
the TTO task should also be discussed. Computer-based
administration of the TTO is currently the standard, and
based on previous studies [52–54], we expected that online
administration would be valid and thus cost-effective.
However, given that the TTO is undoubtedly a cognitively
demanding task, the presence of an interviewer might en-
sure more accuracy in comprehension. Nevertheless, the
pilot testing, the logical relationships of valuations with
severity of depression and participants’ reports concerning
the difficulty of the task are reassuring. Finally, we found
no significant interaction effects of variables related to
perceptions of depression and individual characteristics
with depression group on valuations. This led us to con-
clude that the tested interaction variables cannot explain
the observed discrepancies in depression valuations be-
tween individuals with and without depression. However, it
cannot be ruled out that the interaction effects were not
significant due to the limited power of our study.
Our findings are of major importance for at least two
reasons. Given that mild depression is valued differently
according to the population being asked, we can expect less
favorable outcomes if valuations are obtained from the
general population, rather than from individuals with de-
pression. This effect can be more profound in the case of
interventions specifically targeting mild depression [55]. In
contrast, in the case of interventions targeting individuals
with moderate and severe depression, the choice of
population does not seem to have an impact. Nevertheless,
given that the population’s perspective correlates with
more negative valuations in the case of somatic conditions,
choosing the population’s perspective may entail not pri-
oritizing mental health interventions in the agenda of health
policy makers. Secondly, although we have hypothesized
that various variables related to perceptions of depression
and individual characteristics would explain discrepancies
in perception, we found no evidence for their role. One
possible conclusion is that discrepancies are not caused by
upward biases in the general population, related to how
they perceive depression, neither by downward biases of
the individuals experiencing depressions, related to their
individual characteristics. Rather, the discrepancies simply
reflect genuine differences in how patients and the general
population value depression, which is affected by experi-
ences with depression itself. Future studies could therefore
focus on different types of factors, such as focusing illusion
[23], with individuals with depression focusing on the
aspects in their health-related quality of life that are the
most negatively affected by depression, while individuals
without depression also consider aspects not affected by
the condition.
Future investigations could possibly examine discrep-
ancies in valuations of depression between the general
population and inpatients of mental health institutions, as
patients’ awareness of their diagnosis as well as their
perceptions of depression might differ. Future studies
should also examine to what degree the discrepancies ob-
served in the current study can actually affect conclusions
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regarding the effectiveness of depression interventions.
More research could also elaborate on our finding that
valuations of depression are affected by the individual’s
experience with other chronic conditions. Because de-
pression often co-occurs with somatic conditions [56, 57]
and special psychological interventions are developed and
offered to patients with somatic condition [58], further
exploration of the effect of individuals’ somatic conditions
on valuations of depression is warranted. Subsequent
studies could use qualitative and mixed-methods ap-
proaches to identify potential determinants of group dis-
crepancies in valuations not considered in this study.
Furthermore, examination of whether our findings con-
cerning discrepancies and their determinants also apply to
other mental health conditions would be of relevance.
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